(Q67727778)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

10 November 2022

author name string

R. N. Damle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730512

10 November 2022

S. H. Advani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730512

10 November 2022

S. G. Gangal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730512

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

21 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1730512

full work available at URL

10 November 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910500206

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910500206

10 November 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

International Journal of Cancer

10 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

192-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1

31

1860

Carbone

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

In vitro analysis of cell populations involved in Hodgkin's disease lesions and in the characteristic T cell immunodeficiency

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

The biological significance of soluble interleukin-2 receptors in solid tumors

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Increase of serum interleukin 2 receptor level in thermally injured patients

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910500206

10 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730512%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference